From October 1, 2022 to December 31, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 5,260,910 shares, representing 0.9% for CNY 243.27 million under the buyback announced on March 19, 2022.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
48.19 CNY | +0.82% | +0.44% | -15.47% |
May. 21 | Autobio Diagnostics' Unit Gets Nod for Two Products | MT |
Apr. 19 | Autobio Diagnostics' Q1 Profit Jumps 34% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.47% | 3.86B | |
-9.74% | 11.48B | |
-9.80% | 7.64B | |
+27.84% | 5.49B | |
+8.47% | 2.61B | |
-63.81% | 2.42B | |
-9.24% | 2.27B | |
+21.21% | 2.1B | |
-9.38% | 1.76B | |
-7.16% | 1.43B |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.